Rep. Biggs: Big Pharma Won’t Consider Therapeutics Like HCQ or Ivermectin Because of Economic Interests
‘You’ve got to look at the money angle’
Dec 31, 2021 3:00 PM
By Grabien Staff
Current TimeВ 0:00
/
DurationВ -:-
Loaded: 0%
0:00
Stream TypeВ LIVE
Remaining TimeВ --:-
В
1x
2x
1.75x
1.5x
1.25x
1x, selected
0.75x
0.5x
Chapters
descriptions off, selected
captions settings, opens captions settings dialog
captions off, selected
This is a modal window.
The media could not be loaded, either because the server or network failed or because the format is not supported.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
RUSH EXCERPT
BIGGS: “Thanks, lisa, good to be with you. I think he’s right, two reasons. Number one, when he talks about big pharma having other economic interests, they got on a path and they want to keep this path there and these other therapeutics aren’t really going to make them a lot of money, so you’ve got to look at the money angle for short. But then you also have to look at the efficacy of big government married to big pharma here and what you see is kind of this power, this control, this move for that. That’s also what’s going on, in my opinion.”